Scarica l'app Stockscreener
5.73
1.96%
0.11
Dopo l'orario di chiusura:
5.84
0.11
+1.92%
Precedente Chiudi:
$5.62
Aprire:
$5.732
Volume 24 ore:
677.59K
Relative Volume:
0.94
Capitalizzazione di mercato:
$426.97M
Reddito:
-
Utile/perdita netta:
$-27.03M
Rapporto P/E:
-10.23
EPS:
-0.56
Flusso di cassa netto:
$-23.97M
1 W Prestazione:
+5.91%
1M Prestazione:
+32.95%
6M Prestazione:
+43.25%
1 anno Prestazione:
+41.13%
Intervallo 1D:
$5.60
$6.08
Intervallo di 1 settimana:
$5.335
$6.08
Portata 52W:
$2.54
$10.00
Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile
Nome
Corvus Pharmaceuticals Inc
Settore
Industria
Telefono
(650) 900-4520
Indirizzo
863 MITTEN ROAD, BURLINGAME, CA
Confronta CRVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRVS
Corvus Pharmaceuticals Inc
|
5.73 | 422.49M | 0 | -27.03M | -23.97M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-02 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-18 | Iniziato | Oppenheimer | Outperform |
| 2021-12-01 | Ripresa | Jefferies | Buy |
| 2021-05-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-02-10 | Downgrade | Mizuho | Buy → Neutral |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-05-29 | Iniziato | ROTH Capital | Buy |
| 2017-08-24 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2017-05-01 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2016-04-18 | Iniziato | Credit Suisse | Outperform |
| 2016-04-18 | Iniziato | Guggenheim | Buy |
Mostra tutto
Corvus Pharmaceuticals Inc Borsa (CRVS) Ultime notizie
What is Corvus Pharmaceuticals Inc.’s TAM (Total Addressable Market)2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - khodrobank.com
Statistical indicators supporting Corvus Pharmaceuticals Inc.’s strengthQuarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
Is Corvus Pharmaceuticals Inc. stock poised for growthTrade Entry Summary & Precise Buy Zone Identification - Newser
Can momentum traders help lift Corvus Pharmaceuticals Inc.Dip Buying & Short-Term Trading Alerts - Newser
Using R and stats models for Corvus Pharmaceuticals Inc. forecasting2025 Dividend Review & Entry Point Confirmation Signals - Newser
Is Corvus Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Action & Verified Entry Point Detection - Newser
Analyzing drawdowns of Corvus Pharmaceuticals Inc. with statistical toolsJuly 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
Will Corvus Pharmaceuticals Inc. price bounce be sustainableMarket Performance Report & Verified Short-Term Plans - Newser
Short interest data insights for Corvus Pharmaceuticals Inc.Weekly Trade Recap & Verified Momentum Watchlists - Newser
Forecasting Corvus Pharmaceuticals Inc. price range with options dataTake Profit & Expert Curated Trade Setup Alerts - Newser
Published on: 2025-09-03 02:39:15 - Newser
Will earnings trigger a reversal in Corvus Pharmaceuticals Inc.Quarterly Investment Review & Capital Protection Trade Alerts - Newser
Reversal indicators forming on Corvus Pharmaceuticals Inc. stock2025 Market Overview & Fast Moving Stock Trade Plans - Newser
Corvus Pharmaceuticals Inc. stock trend forecastNew Guidance & AI Driven Stock Movement Reports - Newser
Published on: 2025-09-03 09:32:09 - Newser
Will Corvus Pharmaceuticals Inc. outperform its industry peersJuly 2025 Gainers & Reliable Price Action Trade Plans - khodrobank.com
What MACD signals say about Corvus Pharmaceuticals Inc.July 2025 Selloffs & Verified Entry Point Detection - Newser
Exit strategy if you’re trapped in Corvus Pharmaceuticals Inc.IPO Watch & Free Technical Pattern Based Buy Signals - Newser
Does Corvus Pharmaceuticals Inc. meet Warren Buffett’s criteria2025 Dividend Review & Real-Time Chart Breakout Alerts - khodrobank.com
Understanding Corvus Pharmaceuticals Inc.’s price movementWeekly Market Report & Technical Pattern Based Signals - Newser
Why is Corvus Pharmaceuticals Inc. stock going downJuly 2025 Snapshot & Weekly High Return Opportunities - khodrobank.com
Corvus Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
How to monitor Corvus Pharmaceuticals Inc. with trend dashboardsWeekly Stock Summary & Safe Swing Trade Setup Alerts - Newser
Does Corvus Pharmaceuticals Inc. outperform in volatile marketsJuly 2025 Update & Entry Point Confirmation Signals - khodrobank.com
AI Indicators Detect Buy Opportunity in Corvus Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Big Money Moves: Is Corvus Pharmaceuticals Inc. currently under institutional pressureTreasury Yields & Weekly Watchlist for Hot Stocks - خودرو بانک
Regression analysis insights on Corvus Pharmaceuticals Inc. performanceNew Guidance & Free Expert Approved Momentum Trade Ideas - Newser
How to build a custom watchlist for Corvus Pharmaceuticals Inc.Bond Market & Long-Term Growth Portfolio Plans - Newser
What data driven models say about Corvus Pharmaceuticals Inc.’s future2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Analyzing Corvus Pharmaceuticals Inc. with multi timeframe chartsInsider Buying & Daily Stock Trend Watchlist - Newser
Visual trend scoring systems applied to Corvus Pharmaceuticals Inc.Options Play & High Win Rate Trade Tips - Newser
Comparing Corvus Pharmaceuticals Inc. in custom built stock radars2025 AllTime Highs & Free Technical Confirmation Trade Alerts - Newser
Pattern recognition hints at Corvus Pharmaceuticals Inc. upside2025 Key Lessons & Fast Gain Stock Tips - Newser
Published on: 2025-08-31 10:55:38 - Newser
Corvus Pharmaceuticals Inc Azioni (CRVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Corvus Pharmaceuticals Inc Azioni (CRVS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thompson Peter A. | Director |
Jun 27 '25 |
Sale |
4.16 |
1,176,332 |
4,891,894 |
7,165,006 |
| Jones William Benton | See Remarks |
Jun 04 '25 |
Option Exercise |
3.50 |
19,357 |
67,750 |
173,130 |
| MILLER RICHARD A MD | President and CEO |
May 07 '25 |
Option Exercise |
3.50 |
559,073 |
1,956,756 |
1,136,707 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):